| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
phenotype | 0.900 | None | 1.000 | 1 | 0 | 1992 | 2019 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
phenotype | 0.700 | None | 1.000 | 2 | 0 | 1991 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.690 | None | 0.917 | 2 | 0 | 2009 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.600 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
phenotype | 0.400 | None | 0.972 | 3 | 0 | 1997 | 2019 | ||||||||
|
hydroxysteroid 11-beta dehydrogenase 2 | 0.532 | 0.808 | 0.12 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
pancreatic and duodenal homeobox 1 | 0.530 | 0.654 | 1.8E-02 |
|
phenotype | 0.310 | None | 1.000 | 2 | 0 | 2003 | 2010 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.300 | None | 0.941 | 1 | 0 | 2001 | 2019 | ||||||||
|
SIN3 transcription regulator family member A | 0.551 | 0.692 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ATP synthase F1 subunit alpha | 0.604 | 0.731 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.280 | None | 1.000 | 1 | 0 | 2012 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.270 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
phenotype | 0.270 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.250 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.240 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.240 | None | 1.000 | 2 | 0 | 1999 | 2019 | ||||||||
|
insulin like growth factor 2 receptor | 0.518 | 0.731 | 1.00 |
|
phenotype | 0.240 | None | 0.800 | 1 | 0 | 1992 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.240 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
phenotype | 0.230 | None | 1.000 | 2 | 0 | 2004 | 2011 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.230 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.230 | None | 0.750 | 1 | 0 | 2003 | 2017 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
phenotype | 0.220 | None | 1.000 | 2 | 0 | 2005 | 2011 |